Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
D302525-5mg
|
5mg |
10
|
$9.90
|
|
|
D302525-25mg
|
25mg |
8
|
$19.90
|
|
|
D302525-100mg
|
100mg |
3
|
$44.90
|
|
|
D302525-250mg
|
250mg |
1
|
$89.90
|
|
|
D302525-500mg
|
500mg |
4
|
$159.90
|
|
|
D302525-1g
|
1g |
4
|
$279.90
|
|
|
D302525-5g
|
5g |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$1,299.90
|
|
Iron chelator
| Synonyms | Deferoxamine mesilate | Deferoxamine mesylate | Deferoxamine methanesulfonate | Desferrioxamine B mesylate |
|---|---|
| Specifications & Purity | ≥98% |
| Biochemical and Physiological Mechanisms | Iron chelator. Blood-brain barrier permeable. Displays a number of biological actions such as immunomodulation, inhibition of inflammation and atherosclerosis, and reduction of neuronal death. |
| Storage Temp | Store at -20°C,Argon charged |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Action Type | CHELATING AGENT |
| Mechanism of action | Iron chelating agent |
| Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Class | Organic sulfonic acids and derivatives |
| Subclass | Organosulfonic acids and derivatives |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Organosulfonic acids |
| Alternative Parents | Sulfonyls Methanesulfonates Alkanesulfonic acids Acetohydroxamic acids Acetamides Amino acids and derivatives Propargyl-type 1,3-dipolar organic compounds Carboximidic acids Organopnictogen compounds Organic oxides Monoalkylamines Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Not available |
| Substituents | Methanesulfonate - Organosulfonic acid - Sulfonyl - Acetohydroxamic acid - Acetamide - Alkanesulfonic acid - Amino acid or derivatives - Hydroxamic acid - Carboximidic acid - Carboximidic acid derivative - Carboxylic acid derivative - Organic 1,3-dipolar compound - Propargyl-type 1,3-dipolar organic compound - Organosulfur compound - Organooxygen compound - Organonitrogen compound - Primary aliphatic amine - Organopnictogen compound - Organic oxygen compound - Organic nitrogen compound - Amine - Primary amine - Organic oxide - Hydrocarbon derivative - Carbonyl group - Aliphatic acyclic compound |
| Description | This compound belongs to the class of organic compounds known as organosulfonic acids. These are compounds containing the sulfonic acid group, which has the general structure RS(=O)2OH (R is not a hydrogen atom). |
| External Descriptors | methanesulfonate salt |
|
|
|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Pubchem Sid | 504753887 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504753887 |
| IUPAC Name | N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid |
| INCHI | InChI=1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4) |
| InChIKey | IDDIJAWJANBQLJ-UHFFFAOYSA-N |
| Smiles | CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O |
| Isomeric SMILES | CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O |
| Molecular Weight | 656.79 |
| Reaxy-Rn | 4122177 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=4122177&ln= |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | May 21, 2025 | D302525 | |
| Certificate of Analysis | May 21, 2025 | D302525 | |
| Certificate of Analysis | May 21, 2025 | D302525 | |
| Certificate of Analysis | May 21, 2025 | D302525 | |
| Certificate of Analysis | May 21, 2025 | D302525 | |
| Certificate of Analysis | May 21, 2025 | D302525 | |
| Certificate of Analysis | May 21, 2025 | D302525 | |
| Certificate of Analysis | Jun 29, 2024 | D302525 | |
| Certificate of Analysis | Jun 29, 2024 | D302525 | |
| Certificate of Analysis | Jun 29, 2024 | D302525 | |
| Certificate of Analysis | Jun 29, 2024 | D302525 | |
| Certificate of Analysis | Jun 29, 2024 | D302525 | |
| Certificate of Analysis | Jun 29, 2024 | D302525 | |
| Certificate of Analysis | Jun 29, 2024 | D302525 | |
| Certificate of Analysis | Jun 29, 2024 | D302525 | |
| Certificate of Analysis | Jun 29, 2024 | D302525 | |
| Certificate of Analysis | Mar 07, 2024 | D302525 | |
| Certificate of Analysis | Mar 07, 2024 | D302525 | |
| Certificate of Analysis | Mar 07, 2024 | D302525 | |
| Certificate of Analysis | Mar 07, 2024 | D302525 | |
| Certificate of Analysis | Mar 07, 2024 | D302525 | |
| Certificate of Analysis | Mar 07, 2024 | D302525 | |
| Certificate of Analysis | Mar 07, 2024 | D302525 | |
| Certificate of Analysis | Oct 21, 2023 | D302525 | |
| Certificate of Analysis | Oct 21, 2023 | D302525 | |
| Certificate of Analysis | Oct 21, 2023 | D302525 | |
| Certificate of Analysis | Oct 21, 2023 | D302525 | |
| Certificate of Analysis | Oct 21, 2023 | D302525 | |
| Certificate of Analysis | Oct 21, 2023 | D302525 | |
| Certificate of Analysis | Oct 21, 2023 | D302525 | |
| Certificate of Analysis | Oct 21, 2023 | D302525 | |
| Certificate of Analysis | Oct 21, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Jun 12, 2023 | D302525 | |
| Certificate of Analysis | Feb 01, 2023 | D302525 | |
| Certificate of Analysis | Feb 01, 2023 | D302525 | |
| Certificate of Analysis | Feb 01, 2023 | D302525 | |
| Certificate of Analysis | Feb 01, 2023 | D302525 | |
| Certificate of Analysis | Feb 01, 2023 | D302525 | |
| Certificate of Analysis | Feb 01, 2023 | D302525 | |
| Certificate of Analysis | Feb 01, 2023 | D302525 | |
| Certificate of Analysis | Aug 01, 2022 | D302525 | |
| Certificate of Analysis | Aug 01, 2022 | D302525 | |
| Certificate of Analysis | Aug 01, 2022 | D302525 | |
| Certificate of Analysis | Aug 01, 2022 | D302525 | |
| Certificate of Analysis | Aug 01, 2022 | D302525 | |
| Certificate of Analysis | Aug 01, 2022 | D302525 |
| Sensitivity | Moisture sensitive、Air sensitive、Heat sensitive |
|---|---|
| Molecular Weight | 656.800 g/mol |
| XLogP3 | |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 23 |
| Exact Mass | 656.341 Da |
| Monoisotopic Mass | 656.341 Da |
| Topological Polar Surface Area | 269.000 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 832.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 2 |
Starting at $37.90
| 1. Haoze Song, Jing Liang, Yuanyuan Guo, Yang Liu, Kuiru Sa, Guohong Yan, Wen Xu, Wei Xu, Lixia Chen, Hua Li. (2024) A potent GPX4 degrader to induce ferroptosis in HT1080 cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 265 (116110). |
| 2. Weimin Yin, Jiao Chang, Jiuyuan Sun, Yuge Zhao, Shiyu Chen, Hui Zhi, Jie Zang, Tingting Zhang, Yongyong Li, Haiqing Dong. (2024) Arginine nanoparticles mediated closed-loop ferroptosis enhancement for T cell activity boosting in cancer immunotherapy. Applied Materials Today, 36 (102047). |
| 3. Wang Shengmei, Guo Qiuyan, Xu Rubing, Lin Peng, Deng Guoyan, Xia Xinhua. (2023) Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma. JOURNAL OF NANOBIOTECHNOLOGY, 21 (1): (1-21). |
| 4. Shan Gao, Wanlin Zhang, Xingxing Zhai, Xue Zhao, Jianxin Wang, Jie Weng, Jianshu Li, Xingyu Chen. (2023) An antibacterial and proangiogenic double-layer drug-loaded microneedle patch for accelerating diabetic wound healing. Biomaterials Science, 11 (2): (533-541). |
| 5. Kai Sun, Jiaying Yu, Jinzhong Hu, Jian Chen, Jia Song, Zhixin Chen, Zhuoer Cai, Zhuoxuan Lu, Liming Zhang, Zhifei Wang. (2022) Salicylic acid-based hypoxia-responsive chemodynamic nanomedicines boost antitumor immunotherapy by modulating immunosuppressive tumor microenvironment. Acta Biomaterialia, 148 (230). |
| 6. Xueyang Jin, Ming Zhang, Jinghui Lu, Ximeng Duan, Jinyao Chen, Yue Liu, Wenqiang Chang, Hongxiang Lou. (2021) Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration. Journal of Advanced Research, 34 (65). |
| 7. Fanjia Dai, Jiaying Zhang, Fengjiao Chen, Xianwu Chen, Celine Jessica Lee, Hongze Liang, Lingling Zhao, Hui Tan. (2024) A Multi-Responsive Hydrogel Combined With Mild Heat Stimulation Promotes Diabetic Wound Healing by Regulating Inflammatory and Enhancing Angiogenesis. Advanced Science, (2408783). |
| 8. Yupei Sun, Qin Lu, Die Dong, Rimei Chen, Zhiping Chen, Zhen Xie, Hongxiang Zhu, Qing Bu, Hui He, Shuangfei Wang. (2024) Engineering a monitoring-therapeutic in situ hydrogel via a cellulose-integrated nanointerface. CHEMICAL ENGINEERING JOURNAL, 482 (149015). |
| 9. Wajiha Ahmed, Shifen Li, Min Liang, Yongyuan Kang, Xiaoqing Liu, Changyou Gao. (2024) Multifunctional Drug- and AuNRs-Loaded ROS-Responsive Selenium-Containing Polyurethane Nanofibers for Smart Wound Healing. ACS Biomaterials Science & Engineering, 10 (6): (3946-3957). |
| 10. Weichen Sun, Xiaoting Zuo, Yu Zhang, Chengyan Zhou, Shuai Guo, Wenjuan Li, Mingtao Run, Jianglei Qin. (2024) Quaternary ammonium grafted chitosan hydrogel with enhanced antibacterial performance as tannin acid and deferoxamine carrier to promote diabetic wound healing. COLLOIDS AND SURFACES B-BIOINTERFACES, 244 (114160). |